Recurrences Withdrawn Phase 2 / 3 Trials for Ranolazine (DB00243)

Back to Recurrences

Also known as: Recurrence

IndicationStatusPhase
DBCOND0050633 (Recurrences)Withdrawn2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03162120Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial FibrillationTreatment